MSCT肝包膜侵犯征象对肝癌微血管侵犯诊断价值研究

发布时间：2018-05-28 17:07

  本文选题：MSCT + 肝癌　； 参考：《临床放射学杂志》2017年06期

【摘要】：目的探讨MSCT肝包膜侵犯征象对肝癌微血管侵犯(MVI)的诊断价值。方法回顾性分析初诊经手术病理证实的单发肝癌132例,所有病例术前均行MSCT平扫及多期增强扫描。将MSCT肝包膜侵犯征象与手术病理结果进行对照分析。结果 MSCT肝包膜侵犯征象与病理肝包膜侵犯、肝癌MVI之间存在显著关联(P0.01);MSCT肝包膜侵犯征象诊断肝癌MVI的敏感度、特异度、准确率分别为83.3%(40/48)、67.9%(57/84)、73.5%(97/132)。结论 MSCT肝包膜侵犯征象可以作为评估肝癌MVI的一种依据。
[Abstract]:Objective to evaluate the diagnostic value of MSCT hepatic capsule invasion in hepatocellular carcinoma (HCC) with microvessel invasion. Methods A retrospective analysis was made on 132 cases of primary hepatic carcinoma confirmed by surgery and pathology. All cases were performed MSCT plain scan and multiphase enhanced scan before operation. The MSCT hepatic capsule invasion signs were compared with the results of operation and pathology. Results there was a significant correlation between MSCT hepatic capsule invasion and pathological hepatic capsule invasion. The sensitivity, specificity and accuracy of hepatic envelope invasion in diagnosis of liver cancer MVI were 83.340 / 48 / 67.9g / 73.5 / 97 / 132respectively. Conclusion MSCT hepatic capsule invasion can be used as a basis for evaluating liver cancer MVI.
【作者单位】： 广西医科大学附属肿瘤医院放射科;
【基金】：广西科学研究与技术开发计划项目(编号:桂科攻1355005-3-1) 广西卫生和计划生育委员会自筹经费科研项目(编号:Z2016476) 2017年广西研究生教育创新计划项目资助(编号:YCBZ2017042)
【分类号】：R730.44;R735.7
，

本文编号：1947506